Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateSector Deep DivesUploadPipelinePE CyclesBrainAboutHow We Research

Data updated weekly. Not financial advice.

sectoralpha · sector story
Home›Sectors›Chemicals - Organic

Chemicals - Organic — sector analysis & key numbers

Chemicals - Organic is turning around off a trough: 8 of 19 constituents are in price uptrends, and aggregate profit fell 8% in the latest year.

20 companies₹68.8K Cr market value61.9 relative strengthnarrowing rotationheadwind
By Sector Alpha Research · machine-compiled from Screener.in data · Updated 1 July 2026 · Not investment advice
The 30-second answer

Chemicals - Organic groups 20 listed companies worth ₹68,788 Cr combined, and 8 of 19 are in confirmed price uptrends. Aggregate profit moved +38.3% year-on-year in the latest reported quarter. The sector trades at an aggregate P/E of 32.3×, at the 64th percentile of its own history.

Data as of 1 July 2026 · every number traces to its Screener source column · not investment advice.

Key numbers
Companies
20
Total market cap
₹68,788 Cr
Relative strength
61.9
RRG quadrant
narrowing
Weeks in streak
12
In Stage-2 uptrend
8 of 19
Above 200-DMA
11 of 19
Beating NIFTY 500
11 of 19
Latest-quarter revenue
₹7,242 Cr
Latest-quarter profit
₹498 Cr
Aggregate P/E
32.3×
Valuation percentile
64th of its own history
Sector wind
headwind
Data as of
1 July 2026
The verdict

The research read on Chemicals - Organic: turning around off a trough.lifecycle_bucket

All three streams agree on the SHAPE — a depressed-margin organic-chemicals sector attempting to turn off a destocking trough, with the latest curve quarter (operating margin 8.5%→9.6%, PAT 498 Cr) the first hard inflection print and the gate ranking it strongly (rank 16, curve 74, RRG 77.3, rs_3m +21.78). But the DISAGREEMENTS force conviction to the floor: (1) the deterministic ground is normalized cheap but falling — margins at the 0th percentile and still falling, an explicit falling-knife label, not a confirmed study; (2) the move is re-rating-led — the multiple ran +165.5% ahead of +48.7% earnings, the #1 false-positive pattern; (3) aggregate three-year ΔPAT is NEGATIVE (-2,222 Cr) with GFL alone dragging 98.6% of it, so the 'sector' earnings decline is concentrated and breadth is thin; (4) qual is WEAK/on watch, gating on Hormuz feedstock resolution and volume-led margins; (5) social has fallen to 48 and is a shared super-group basket. Lifecycle is turning around with a confirming RRG start, which floors conviction at 55 — but the falling margin direction, re-rating-led move and negative concentrated ΔPAT are cited reasons the turn is not yet confirmed, holding conviction exactly at the floor.synthesis

What would change this view: Two consecutive quarters of rising operating margin off the 9.6% print AND aggregate PAT turning positive ex-GFL would flip this from a falling knife to a confirmed earnings-led turn and justify scoring well above the floor; conversely, the Mar-2026 margin tick proving a head-fake and operating margin rolling back toward 8% confirms a peak-margin-mean-reversion falling knife and pushes conviction below the floor.would_change_my_mind

Specialty/CRAMS volumes inflecting off the end of the destocking cycle and battery-materials optionality building, but Hormuz feedstock spikes, Chinese dumping and export tariffs cap the near-term recovery.one_line_thesis

headwind
  • ✓Sector revenue rose to an all-time high ~29,092 Cr in FY2025 (from 8,034 Cr in FY2015); FY2026 annual not yet fully reported (null). · chemicals-organic.json (curve.annual_fundamentals.revenue)
  • ✓Sector operating margin peaked at 30.14% in FY2023 then collapsed to 10.85% (FY2024) and 9.73% (FY2025) — the lowest annual reading in the array. · chemicals-organic.json (curve.annual_fundamentals.opm)
  • ⚠Sector PAT peaked at 3,982 Cr in FY2023 then halved to 1,931 (FY2024) and slid to 1,779 (FY2025) despite rising revenue. · chemicals-organic.json (curve.annual_fundamentals.pat)
  • ✓Quarterly operating margin bottomed at 8.46% (2025-12) and ticked to 9.61% (2026-03) with PAT recovering to 498 Cr — the first inflection datapoint. · chemicals-organic.json (curve.quarterly_fundamentals)
  • ⚠Deterministic curve_move_driver=re-rating-led: multiple +165.5% over 12q ran far ahead of aggregate earnings +48.7% while price barely moved (+4.1%). · chemicals-organic.json (sector_cycle_deterministic.curve_move_driver)
  • ⚠Deterministic verdict normalized cheap but falling: operating margin 9.7% at the 0th percentile vs mid-cycle 16.65% (falling); trailing PE 50th → normalized PE 28th percentile — cheap optically but a falling knife. · chemicals-organic.json (sector_cycle_deterministic.verdict)
  • ⚠Aggregate three-year ΔPAT is NEGATIVE -2,222 Cr, with GFLLIMITED dragging 98.6% of it; BASF lifted +397 Cr; BALAMINES dragged -237 Cr. · chemicals-organic.json (sector_cycle_deterministic.top_contributors)
  • ✓The gate ranks it strongly: rank 16, curve_score 74, RRG_score 77.3, final 75.65, rs_3m +21.78, rs_1m +7.85 — a confirming RRG start. · chemicals-organic.json (meta)

Research view from 2026-06-27

How the sector is moving

8 of 19 constituents are in Stage-2 price uptrends, 11 trade above their 200-day averages, and 11 are beating the NIFTY 500 on relative strength.stageabove_dma200rs_mansfield

Over the trailing ~20 weeks, the share of constituents above the 200-day line moved from 17% to 56% — participation is widening.breadth_series

Sector relative strength stands at 61.9, in the narrowing quadrant of the rotation map, with relative strength rising over a 12-week streak.current_rsquadrant

Recent stage changes: BALAMINES (stage 4→2), ELANTAS (stage 4→1), INDOAMIN (stage 4→2), KERALACHEM (stage 1→2).stage

8 / 19
In Stage-2 uptrend
11 / 19
Above 200-day avg
11 / 19
Beating NIFTY 500
RRG: narrowingRS 61.9relative strength rising12-week streak
Breadth trend — share of constituents participating% (trailing ~20 weeks)
020406080200-DMAvs NIFTY2026-02-092026-03-302026-05-182026-06-22
Data: Breadth trend
Period% above 200-DMA (%)% beating NIFTY (%)
Feb 2616.76.7
Feb 2616.76.7
Feb 2627.820.0
Mar 2616.713.3
Mar 2613.316.7
Mar 2620.025.0
Mar 266.723.1
Mar 2616.733.3
Apr 2628.642.9
Apr 2629.420.0
Apr 2629.420.0
Apr 2641.226.7
May 2676.546.7
May 2647.140.0
May 2652.940.0
May 2658.846.7
Jun 2658.853.3
Jun 2656.346.7
Jun 2662.560.0
Jun 2656.360.0

Data as of 2026-07-01

The performers

Top performers by 1-year price return: Shri Ahimsa Naturals Ltd (+196.4%), Nitta Gelatin India Ltd (+113.4%), Sacheerome Ltd (+97.3%), Balaji Amines Ltd (+16.2%), Foseco India Ltd (+6.2%).price

by 1-year return
Sector avg
Indexed price (base 100, ~52 weeks)index
Data: Indexed price (base 100, ~52 weeks) — default top-5
PeriodSHRIAHIMSA (index)KERALACHEM (index)SACHEEROME (index)BALAMINES (index)FOSECOIND (index)Sector avg (index)
Jul 25100100100100100100
Jul 2511196.488.398.2104101
Jul 2511794.283.893.710197.9
Aug 2513194.797.694.211197.6
Aug 2512782.386.885.510091.4
Aug 2512284.289.486.310191.6
Aug 2513183.984.485.413495.2
Aug 2514382.595.981.212994.4
Sep 2514385.495.482.913495.4
Sep 2515490.510183.812798.3
Sep 2515893.310982.612599.3
Sep 2514688.910078.612093.3
Oct 2514888.610579.011694.7
Oct 2514884.899.876.311492.7
Oct 2514986.397.076.111991.7
Oct 2515886.810377.711794.0
Oct 2516190.210678.511893.0
Nov 2517583.810477.911492.1
Nov 2517882.614768.511392.0
Nov 2517282.617065.710891.4
Nov 2517983.117264.210891.2
Dec 2516581.516262.811088.1
Dec 2515981.519562.410888.7
Dec 2515582.816962.210487.0
Dec 2516281.816362.610387.8
Jan 2615882.318061.810288.4
Jan 2615579.819664.999.086.6
Jan 2615579.818771.095.984.9
Jan 2615278.417562.993.580.1
Feb 2614686.817762.791.080.7
Feb 2617784.517762.798.985.3
Feb 2617385.717060.199.284.6
Feb 2615685.917460.798.082.3
Feb 2615984.618660.611182.7
Mar 2615482.018258.210778.8
Mar 2615080.717755.898.478.8
Mar 2615881.615659.510979.1
Mar 2616178.513457.610173.9
Apr 2615480.0–59.4–80.8
Apr 2616082.6–60.0–83.1
Apr 2617586.317263.597.386.8
Apr 2617693.116969.797.786.5
Apr 2617698.515974.397.986.8
May 2617212816782.910592.9
May 2619213415495.110591.8
May 2619414316010210594.0
May 2619816315898.910395.7
Jun 2624216515411410099.3
Jun 26229–15711910295.7
Jun 26244–15511910999.7
Jun 26282–151111108101
Jul 26288–151117110102
Quarterly revenue (8q)₹ Cr
Data: Quarterly revenue (8q) — default top-5
PeriodSHRIAHIMSA (₹ Cr)KERALACHEM (₹ Cr)SACHEEROME (₹ Cr)BALAMINES (₹ Cr)FOSECOIND (₹ Cr)Sector avg (₹ Cr)
Jun 24–131–385–414
Sep 2441.013250.0347–401
Dec 24–135–313136385
Mar 2555.012957.0353149348
Jun 25–139–358–421
Sep 2561.013877.0341151371
Dec 25–150–331189401
Mar 2663.016276.0395202426
Quarterly net profit (8q)₹ Cr
Data: Quarterly net profit (8q) — default top-5
PeriodSHRIAHIMSA (₹ Cr)KERALACHEM (₹ Cr)SACHEEROME (₹ Cr)BALAMINES (₹ Cr)FOSECOIND (₹ Cr)Sector avg (₹ Cr)
Jun 24–19.0–46.0–31.6
Sep 2410.020.07.041.0–22.6
Dec 24–24.0–31.020.022.8
Mar 2512.019.09.040.022.018.1
Jun 25–19.0–37.0–20.1
Sep 2515.026.015.037.016.022.6
Dec 25–31.0–31.015.020.5
Mar 2615.034.014.065.033.029.4
Operating margin % (8q)%
Data: Operating margin % (8q) — default top-5
PeriodSHRIAHIMSA (%)KERALACHEM (%)SACHEEROME (%)BALAMINES (%)FOSECOIND (%)Sector avg (%)
Jun 24–21.0–17.0–-230
Sep 2434.019.019.017.0–-2.2
Dec 24–20.0–15.017.018.4
Mar 2530.018.022.017.018.0-117
Jun 25–20.0–15.0–-50.2
Sep 2530.019.025.018.018.018.0
Dec 25–25.0–17.022.016.8
Mar 2628.028.023.024.020.016.1
Latest reported ROCE / ROE (single latest reading, not a trend)%
Data: Latest reported ROCE / ROE (single latest reading, not a trend) — default top-5
PeriodSHRIAHIMSA (%)KERALACHEM (%)SACHEEROME (%)BALAMINES (%)FOSECOIND (%)Sector avg (%)
ROCE %21.731.335.711.017.4-92.2
ROE %16.724.927.08.712.612.7
10-year valuation percentile (latest)percentile
Data: 10-year valuation percentile (latest) — default top-5
PeriodSHRIAHIMSA (percentile)KERALACHEM (percentile)SACHEEROME (percentile)BALAMINES (percentile)Sector avg (percentile)
10y percentile83.010.033.095.057.5

Interactive charts default to the five strongest performers by 1-year price return; use the rail to add or remove any constituent, globally or per chart. Non-interactive readers see the same numbers in each chart’s data table.

Data as of 2026-07-01

⚠ How they're scaling

In the latest reported quarter (2026-03), constituents together booked ₹7,242 Cr of revenue (+4.1% year-on-year) and ₹498 Cr of profit (+38.3%).revenuepat

Reporting honesty note: 17 of the constituents have reported this quarter versus 20 a year ago, so part of the year-on-year change is composition, not like-for-like growth.reporters

On the annual arc, aggregate profit fell 8% to ₹1,779 Cr in 2025.pat

Aggregate quarterly revenue₹ Cr
02,5005,0007,500Jun 23Jun 24Jun 25Mar 26
Data: Aggregate quarterly revenue
PeriodRevenue (₹ Cr)Reporters
Jun 233,00514
Sep 232,89115
Dec 236,06516
Mar 246,42616
Jun 247,03917
Sep 247,61219
Dec 246,93218
Mar 256,95820
Jun 257,15117
Sep 257,42020
Dec 257,21418
Mar 267,24217
Aggregate quarterly profit₹ Cr
0200400Jun 23Jun 24Jun 25Mar 26
Data: Aggregate quarterly profit
PeriodProfit after tax (₹ Cr)
Jun 23311
Sep 23301
Dec 23426
Mar 24483
Jun 24536
Sep 24429
Dec 24410
Mar 25360
Jun 25341
Sep 25451
Dec 25369
Mar 26498
Aggregate operating margin%
8.010.012.014.016.0Jun 23Jun 24Jun 25Mar 26
Data: Aggregate operating margin
PeriodOPM (%)
Jun 2315.7
Sep 2313.9
Dec 2310.4
Mar 2411.3
Jun 2411.1
Sep 249.3
Dec 249.3
Mar 258.4
Jun 259.1
Sep 258.9
Dec 258.5
Mar 269.6
Aggregate profit by year₹ Cr
02,0004,0002015201920232026
Data: Aggregate profit by year
PeriodProfit after tax (₹ Cr)
2015780
2016860
2017580
2018663
20191,950
2020487
2021532
20221,196
20233,982
20241,931
20251,779
2026–
Aggregate operating margin by year%
10.020.030.02015201920232026
Data: Operating margin by year
PeriodOPM (%)
201516.8
201617.5
201717.3
201816.7
201916.0
202013.7
202117.2
202216.5
202330.1
202410.9
20259.7
2026–

Data as of 2026-06-27

⚠ The WHY behind the numbers

Sector revenue moved from ₹26,663 Cr to ₹29,092 Cr (+9.1% year-on-year).revenue

Aggregate operating margin moved 10.8%→9.7% year-on-year (-112 basis points).opm

The aggregate P/E moved from 12.2× to 32.3× (+165.5%) while sector profits moved +48.7% — the multiple ran ahead of earnings — the pattern that most often disappoints.pe

Capital cycle: the capital-flow signals are mixed — institutions and capex point in opposite directions, with constituent capex running +28.5% year-on-year.readcapex_yoy_pct

✓Sector Σrevenue (annual YoY)+9.1%

Sector Σrevenue +9.1% but ΣPAT only -7.9% — topline not converting; aggregate net margin (-1.13pp) / cost is the gap.

revenuepat_margin
✓Sector aggregate OPM (annual YoY)−10.3%

Sector aggregate OPM -112bps down — split input-cost (raw material / commodity) vs mix vs operating-deleverage; capex ramp (new capacity not yet utilized) also drags. Corroborate the driver in the qual bundle.

opmpat_margin
✓Sector PE re-rating (12q)+165.5%

Sector PE expanded +165.5% while aggregate ΣPAT only +48.7% over ~3y — the MULTIPLE ran ahead of earnings (the #1 false-positive: re-rating without EPS). Demand the EPS to grow INTO the multiple before treating the sector as a fresh setup; cite the ΣPAT curve.

peprice_idxpat
✓Sector capital-flow (capex + institutions)+28.5%

Capital is ENTERING (read=MIXED; capex +28.53%, FII+DII -0.3pp) — crowding in + a capex surge LATE in the cycle is a HEADWIND (supply coming, competition for returns). Check whether the inflow is EARLY (depressed valuation, fresh turn) or LATE (chasing a run).

capex_yoy_pctfii_dii_delta_4qcwip_growth_pct
✓Sector breadth trend (% above 200-DMA)+200.3%

Sector breadth WIDENING — % above 200-DMA 19→58% over the trailing weeks: broad participation corroborates a genuine sector-wide turn rather than a few-name move.

pct_above_200dmapct_outperforming

Research view from 2026-06-27

Capital cycle

Ownership: institutional (FII+DII) holdings moved -0.3 percentage points over four quarters; promoter stakes moved -0.4 points over two.fii_dii_delta_4qpromoter_delta_2q

Constituents spent ₹2,496 Cr on capex in the trailing twelve months (+28.5% year-on-year), with gross block growing +20.4%.capex_ttm_sum_crcapex_yoy_pct

The deterministic capital-flow signals are mixed — institutions and capex point in opposite directions for this industry.read

capital mixed
FII+DII (4q)−0.30 pp
Promoter (2q)−0.40 pp
Capex TTM₹2,496 Cr
Capex YoY+28.5%
Gross block+20.4%

Research view from 2026-06-27

Valuation vs its own history

The sector trades at an aggregate P/E of 32.31× against a range of 8.58–138.95× over its 40-quarter history.pe

The median constituent sits at the 64th percentile of its own 10-year valuation range.percentile

The multiple has expanded faster than aggregate earnings over the trailing window — the re-rating is running ahead of delivered profits.opm

P/E 32.3×64th percentile of its 10-yr range
Aggregate P/E vs its own history×
0.050.0100.0P/E2016-062019-122023-062026-03
Data: Aggregate P/E and price index
PeriodP/E (×)Price index
Jun 169.8100
Sep 1610.7107
Dec 1610.9107
Mar 1722.2125
Jun 1725.9144
Sep 1722.9128
Dec 1732.6184
Mar 1826.5163
Jun 1826.2160
Sep 1827.1165
Dec 1827.7170
Mar 199.7170
Jun 199.3164
Sep 198.6152
Dec 198.9157
Mar 2044.2143
Jun 2053.7173
Sep 2072.1231
Dec 2031.5248
Mar 2175.9283
Jun 21100.4374
Sep 21139.0514
Dec 21117.1448
Mar 2252.0442
Jun 2247.7406
Sep 2258.0495
Dec 2250.6433
Mar 2312.2348
Jun 2314.4410
Sep 2316.1423
Dec 2318.0471
Mar 2432.2423
Jun 2440.9534
Sep 2446.9630
Dec 2440.1525
Mar 2535.2417
Jun 2548.6512
Sep 2544.3473
Dec 2539.4412
Mar 2632.3363

The multiple has expanded faster than aggregate earnings over the trailing window — the re-rating is running ahead of delivered profits.

Data as of 2026-06-27

The companies

20 companies make up this sector, led by Fine Organic Industries Ltd at ₹16,054 Cr of market value.constituents

CompanyPrice1yStageRS10y val %
Fine Organic Industries Ltd₹5,209−1.1%212.964
BASF India Ltd₹3,565−30.8%4-11.48
Elantas Beck India Ltd₹10,395−12.5%16.484
Balaji Amines Ltd₹2,090+16.2%249.295
Laxmi Organic Industries Ltd₹155−21.1%4-7.152
Foseco India Ltd₹5,318+6.2%12.7–
Citurgia Biochemicals Ltd₹143––––
Nitta Gelatin India Ltd₹1,641+113.4%285.710
Oriental Aromatics Ltd₹315−14.7%20.197
Indo Amines Ltd₹132−20.7%23.312
Shri Ahimsa Naturals Ltd₹439+196.4%273.483
Jyoti Resins and Adhesives Ltd₹831−33.3%4-30.317
Sigachi Industries Ltd₹23.4−47.9%4-19.675
Gem Aromatics Ltd₹191–4––
Fairchem Organics Ltd₹732−25.9%46.390
Valiant Organics Ltd₹275−35.4%1-5.957
Sacheerome Ltd₹315+97.3%25.033
OCCL Ltd₹126–213.240
Shree Ganesh Remedies Ltd₹495−32.1%4-9.971
GFL Ltd₹46.1−28.9%4-15.090

Data as of 2026-07-01

What is NOT happening

Aggregate earnings are NOT keeping pace with the multiple — the valuation has expanded faster than sector profits over the trailing window.valuation_seriespat

Institutional money is NOT yet crowding in: FII+DII holdings moved just -1.03 percentage points across constituents over the last two quarters — the capital-flow read is mixed.fii_dii_delta_2qread

  • Aggregate earnings are NOT keeping pace with the multiple — the valuation has expanded faster than sector profits over the trailing window.
  • Institutional money is NOT yet crowding in: FII+DII holdings moved just -1.03 percentage points across constituents over the last two quarters — the capital-flow read is mixed.

Data as of 2026-07-01

Frequently asked questions

Straight answers from the data

What is the Chemicals - Organic sector?

The Chemicals - Organic sector groups 20 listed companies with a combined market value of ₹68,788 Cr, led by Fine Organic Industries Ltd, BASF India Ltd, Elantas Beck India Ltd. 8 of 19 constituents are currently in confirmed price uptrends.

Which stocks are in the Chemicals - Organic sector?

The largest Chemicals - Organic companies by market value are Fine Organic Industries Ltd (₹16,054 Cr), BASF India Ltd (₹15,810 Cr), Elantas Beck India Ltd (₹8,526 Cr), Balaji Amines Ltd (₹6,445 Cr), Laxmi Organic Industries Ltd (₹4,434 Cr), Foseco India Ltd (₹3,985 Cr), Citurgia Biochemicals Ltd (₹1,884 Cr), Nitta Gelatin India Ltd (₹1,489 Cr).

What are the best-performing Chemicals - Organic stocks?

By 1-year price return as of 1 July 2026, the strongest Chemicals - Organic stocks are Shri Ahimsa Naturals Ltd (+196%), Nitta Gelatin India Ltd (+113%), Sacheerome Ltd (+97%), Balaji Amines Ltd (+16%), Foseco India Ltd (+6.2%). These are descriptive price moves measured from weekly Screener closes, not recommendations.

Is the Chemicals - Organic sector in an uptrend?

8 of 19 Chemicals - Organic constituents are in Stage-2 price uptrends, 11 trade above their 200-day average, and 11 are beating the NIFTY 500 on relative strength. Sector relative strength reads 61.9, in the narrowing quadrant of the rotation map, rising over a 12-week streak.

How many Chemicals - Organic stocks trade above their 200-day average?

11 of 19 Chemicals - Organic constituents currently trade above their 200-day moving average. Over the trailing ~20 weeks, that share moved from 17% to 56% — participation is widening.

Is the Chemicals - Organic sector expensive versus its own history?

The Chemicals - Organic sector trades at an aggregate P/E of 32.3× against a 8.58–139× band over its own history. The median constituent sits at the 64th percentile of its own 10-year P/E range, above the middle of its own historical range. The multiple has expanded faster than aggregate earnings over the trailing window — the re-rating is running ahead of delivered profits.

Is money entering or leaving the Chemicals - Organic sector?

On Sector Alpha's deterministic capital-flow read, money is sending mixed signals across the Chemicals - Organic sector. Institutional (FII+DII) holdings moved −0.30 percentage points across constituents over the last four quarters, and constituents grew capex +28.5% year-on-year.

How fast is the Chemicals - Organic sector growing?

In the latest reported quarter (March 2026), Chemicals - Organic constituents together booked ₹7,242 Cr of revenue, +4.1% year-on-year, with aggregate profit +38.3% year-on-year. Figures aggregate Screener-scraped quarterly filings across the sector.

How are Chemicals - Organic operating margins trending?

Aggregate Chemicals - Organic operating margin was 9.6% in the latest reported quarter (March 2026), versus 8.4% a year earlier — margins are improving.

What could change the view on the Chemicals - Organic sector?

Two consecutive quarters of rising operating margin off the 9.6% print AND aggregate PAT turning positive ex-GFL would flip this from a falling knife to a confirmed earnings-led turn and justify scoring well above the floor; conversely, the Mar-2026 margin tick proving a head-fake and operating margin rolling back toward 8% confirms a peak-margin-mean-reversion falling knife and pushes conviction below the floor. Also worth noting: aggregate earnings are NOT keeping pace with the multiple — the valuation has expanded faster than sector profits over the trailing window.

Should I invest in the Chemicals - Organic sector?

Sector Alpha does not publish sector allocations or trading calls — for Chemicals - Organic or any sector. What this page provides is a data-first read: how many constituents are in confirmed uptrends, how the sector's valuation compares with its own history, where earnings sit in their cycle, and whether capital is entering or leaving. Use it to study the sector on the evidence, then do your own diligence.

What is the Chemicals - Organic sector's relative-strength position?

Chemicals - Organic relative strength reads 61.9 on Sector Alpha's rotation map, placing it in the narrowing quadrant. Relative strength is rising and has held for 12 weeks. A positive, rising relative-strength trend means the sector has been outperforming the broad market week after week.

Generated from Screener data · 10 sources · sector_why_traces/1.0 + sector-story/1.0 · GOLD

Machine-compiled sector commentary derived from the constituent companies. Descriptive research only — Sector Alpha does not publish sector allocations, price targets, or buy/sell calls. Not investment advice.